Catalent Inc Net Income per Employee (CTLT), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Catalent Inc   (NYSE: CTLT)
 

Catalent Inc Net Income per Employee

CTLT's Quarterly Results, Trends, Rankings, Statistics
Catalent Inc recorded a cumulative net loss of $-413 million during 12 month ending in the first quarter 2025.
The Healthcare sector has seen employees of 74 other companies achieving higher income per employee. While Catalent Inc 's total ranking has deteriorated compared to the previous quarter from 2150 to 2842.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CTLT Net Income per Employee (Sep 30 2024)
I. Quarter		 (Jun 30 2024)
IV. Quarter		 (Mar 31 2024)
III. Quarter		 (Dec 31 2023)
II. Quarter		 (Sep 30 2023)
I. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -24,438 -61,716 -69,586 -77,041 -60,059
CTLT's Total Ranking # 2842 # 2150 # 2006 # 1973 # 0
Seq. Net Income Change - - - - -

CTLT Company Profile >> Back to CTLT Efficiency Comparisons >> Compare CTLT Net Income per Employee to its Competitors

CTLT Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 75
Healthcare Sector # 241
Overall Market # 2842

Net Income per Employee Statistics
High Average Low
$ 32,947 $ 1,176 $ -77,041
(Mar 31 2021)   (Dec 31 2023)




  News about Catalent Inc Income per employee

Catalent Harnesses $600 Million in New Term Loans to Surge Forward Amidst Financial Hurdles



In an effort to fortify its position as the global leader in developing and providing advanced treatments for patients worldwide, Catalent, Inc. recently announced a significant financial move. The company s wholly owned subsidiary, Catalent Pharma Solutions, Inc., has entered into an amendment to its existing credit agreement, paving the way for the issuance of new incremental term loans totaling $600 million. This development comes in light of Catalent Inc s net loss of $1 billion during the twelve-month period ending in the first quarter of 2024.
Assessment of the Facts:
1. Incremental Term Loans: Catalent s decision to raise additional funds through incremental term loans holds immense potential to drive growth and innovation within the company. This influx of capital will likely be utilized for strategic investments, such as research and development, expanding manufacturing capabilities, and potential acquisitions. By bolstering its financial resources, Catalent aims to enhance its ability to deliver cutting-edge treatments to patients globally.




Companies with similar Income per Employee for 12 month ending Sep 30 2024, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2024Number of Employees Sep 30 2024


Date modified: 2026-09-08T15:11:22+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.